Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy Srinivas

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
American Journal of Clinical Oncology|October 8, 2008
The combination of thalidomide and capecitabine in metastatic renal cell carcinoma -- is not the answerLauren C Harshman, Mingqing Li, Sandy Srinivas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Pyoderma gangrenosum with the use of sunitinibLincoln D Nadauld, Martin B Miller, Sandy Srinivas
Journal of Andrology|June 30, 2004
Flutamide administration at 500 mg daily has similar effects on serum testosterone to 750 mg dailyJeremiah C Murphy, Sandy Srinivas, Martha K Terris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatmentJoanna Badger, Sewon Kang, Alison Uzieblo, et al.
International Journal of Surgical Pathology|September 20, 2024
Incidence and Pitfalls of Adipose Tissue Encountered in Urinary Bladder Biopsy/Transurethral Resection SpecimensCarol N Rizkalla, Sandy Srinivas, Ankur R Sangoi
Urology|May 16, 2006
Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancerSandy Srinivas, Aruna V Krishnan, Natalia Colocci, et al.
Clinical Genitourinary Cancer|January 29, 2013
A phase II study of bevacizumab and everolimus as treatment for refractory metastatic renal cell carcinomaLauren C Harshman, Sarah Barbeau, Alex McMillian, et al.
Plos One|April 29, 2016
Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell CarcinomaRyogo Minamimoto, Amir Barkhodari, Lauren Harshman, et al.
Nature Reviews. Urology|June 6, 2009
Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinibLauren C Harshman, Sandy Srinivas, Aya Kamaya, et al.
Oncotargets and Therapy|October 24, 2022
Immunotherapy for Urothelial Carcinoma: Focus on Clinical Utility of NivolumabRyan S Chiang, Michael J Glover, Ali Raza Khaki, et al.
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
American Journal of Clinical Oncology|October 8, 2008
The combination of thalidomide and capecitabine in metastatic renal cell carcinoma -- is not the answerLauren C Harshman, Mingqing Li, Sandy Srinivas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Pyoderma gangrenosum with the use of sunitinibLincoln D Nadauld, Martin B Miller, Sandy Srinivas
Journal of Andrology|June 30, 2004
Flutamide administration at 500 mg daily has similar effects on serum testosterone to 750 mg dailyJeremiah C Murphy, Sandy Srinivas, Martha K Terris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatmentJoanna Badger, Sewon Kang, Alison Uzieblo, et al.
International Journal of Surgical Pathology|September 20, 2024
Incidence and Pitfalls of Adipose Tissue Encountered in Urinary Bladder Biopsy/Transurethral Resection SpecimensCarol N Rizkalla, Sandy Srinivas, Ankur R Sangoi
Urology|May 16, 2006
Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancerSandy Srinivas, Aruna V Krishnan, Natalia Colocci, et al.
Clinical Genitourinary Cancer|January 29, 2013
A phase II study of bevacizumab and everolimus as treatment for refractory metastatic renal cell carcinomaLauren C Harshman, Sarah Barbeau, Alex McMillian, et al.
Plos One|April 29, 2016
Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell CarcinomaRyogo Minamimoto, Amir Barkhodari, Lauren Harshman, et al.
Nature Reviews. Urology|June 6, 2009
Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinibLauren C Harshman, Sandy Srinivas, Aya Kamaya, et al.
Oncotargets and Therapy|October 24, 2022
Immunotherapy for Urothelial Carcinoma: Focus on Clinical Utility of NivolumabRyan S Chiang, Michael J Glover, Ali Raza Khaki, et al.
Pageof 16